Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW Trial

Authors:

Abstract
No abstract available
Funding Information
  • Allergan
  • GlaxoSmithKline
  • Novartis Pharma AG
  • Novartis
  • Shire
  • NIHR Great Ormond Street Hospital Biomedical Research Centre
  • Bayer
  • Roche

This publication has 19 references indexed in Scilit: